These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6326950)

  • 1. Thyrotropin-releasing hormone (TRH) improves survival in anaphylactic shock: a central effect mediated by the sympatho-adrenomedullary beta-adrenoceptive system.
    Amir S; Harel M; Schachar A
    Brain Res; 1984 Apr; 298(2):219-24. PubMed ID: 6326950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-anaphylactic action in the mouse of thyrotropin-releasing hormone (TRH) is mediated through beta 1-adrenoceptive effectors.
    Amir S
    Neurosci Lett; 1984 May; 46(2):127-30. PubMed ID: 6330618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of i.c.v. naloxone in anaphylactic shock is mediated through peripheral beta-adrenoceptive mechanisms.
    Amir S
    Brain Res; 1984 Jan; 290(1):191-4. PubMed ID: 6318909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.
    Sirén AL; Lake CR; Feuerstein G
    Circ Res; 1988 Jan; 62(1):139-54. PubMed ID: 2891452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylactic shock: catecholamine actions in the responses to opioid antagonists.
    Amir S
    Prog Clin Biol Res; 1988; 264():265-74. PubMed ID: 2454493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
    Evequoz D; Burnier M; Niederberger M; Brunner HR; Nussberger J; Waeber B
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):93-100. PubMed ID: 8039276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone potently reverses epinephrine-stimulated hyperglycemia in mice.
    Amir S; Harel M; Rivkind AI
    Brain Res; 1987 Dec; 435(1-2):112-22. PubMed ID: 3123010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianaphylactic effect of naloxone in mice is mediated by increased central sympathetic outflow to sympathetic nerve endings and adrenal medulla.
    Amir S
    Brain Res; 1983 Sep; 274(1):180-3. PubMed ID: 6412966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of leukotriene D4 hypotension by thyrotropin releasing hormone.
    Lux WE; Feuerstein G; Faden AI
    Nature; 1983 Apr; 302(5911):822-4. PubMed ID: 6405279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of gamma-endorphin-type peptides in anaphylactic shock.
    Amir S; van Ree JM
    Brain Res; 1985 Mar; 329(1-2):329-33. PubMed ID: 2579712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of brain adrenoceptors in the corticortopin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats.
    Yorimitsu M; Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Yokotani K
    Life Sci; 2008 Feb; 82(9-10):487-94. PubMed ID: 18201726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endorphins contribute to the loss of glucose homeostasis in anaphylactic shock.
    Amir S
    NIDA Res Monogr; 1986; 75():375-8. PubMed ID: 3123954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic vasoconstriction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):232-6. PubMed ID: 3088259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
    Okuda C; Mizobe T; Miyazaki M
    Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrally administered thyrotropin-releasing hormone in the regulation of regional blood flow to brown adipose tissue in rats.
    Uchida Y; Nomoto T
    Eur J Pharmacol; 1988 May; 149(3):257-65. PubMed ID: 3137079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRH-induced vagal stimulation of duodenal HCO-3 mediated by VIP and muscarinic pathways.
    Lenz HJ; Vale WW; Rivier JE
    Am J Physiol; 1989 Nov; 257(5 Pt 1):G677-82. PubMed ID: 2531983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric hypersecretion by intracisternal TRH: dissociation from hypophysiotropic activity and role of central catecholamine.
    Taché Y; Lesiege D; Vale W; Collu R
    Eur J Pharmacol; 1985 Jan; 107(2):149-55. PubMed ID: 3920055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin-releasing hormone blocks neurally-mediated hyperglycemia through central action.
    Amir S; Butler PD
    Peptides; 1988; 9(1):31-5. PubMed ID: 2896345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TPA (12-O-tetradecanoylphorbol-13-acetate) enhances the central hypoglycemic action of thyrotropin-releasing hormone in mice.
    Amir S
    Brain Res; 1988 May; 450(1-2):369-72. PubMed ID: 3135916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms.
    Bouloux PM; Corsello S; Besser M; Grossman A
    Br J Clin Pharmacol; 1996 Aug; 42(2):225-32. PubMed ID: 8864322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.